University of Alberta: Ischemic Stroke trials
The registry lists 14 Ischemic Stroke studies with University of Alberta as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 7Phase 4 2No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Augmented Renal Clearance in Neurocritical CareRecruitingNCT07410624
- Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME)CompletedNCT07844603Phase 2
- Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)CompletedNCT06638151Phase 2
- Remote Ischemic Conditioning With Novel Optical Sensor Feedback Device in Acute Ischemic StrokeCompletedNCT05408130Not applicable
- PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in StrokeActive, not recruitingNCT04571177
- Eliquis Acute Stroke Safety EvaluationCompletedNCT04435418
- Lixiana Acute Stroke Evaluation RegistryCompletedNCT03494530Phase 4
- Perfusion and Antihypertensive Therapy in Acute Ischemic StrokeCompletedNCT02327793Phase 2
- Dabigatran Following Transient Ischemic Attack and Minor StrokeCompletedNCT02295826Phase 2
- Rivaroxaban Acute Stroke Safety StudyCompletedNCT02279940
- Asia Africa Streptokinase TrialWithdrawnNCT02150785Phase 2
- Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic StrokeCompletedNCT02101606Phase 2
- Dabigatran Treatment Following Transient Ischemic Attack and Minor StrokeCompletedNCT01769703Phase 2
- Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic AttackCompletedNCT00931788Phase 4